Stock BPMC BLUEPRINT MEDICINES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
106.7 USD -1.51% Intraday chart for Blueprint Medicines Corporation -0.46% +15.68%
May. 06 Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing MT
May. 06 Goldman Sachs Adjusts Price Target on Blueprint Medicines to $168 From $121, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BLUEPRINT MEDICINES CORPORATION
Other Biotechnology & Medical Research
-1.51%-0.46%+15.68%+97.52%+27.54% 6.68B
Bullish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. BPMC Stock
  4. Charts Blueprint Medicines Corporation
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW